Svetlana V. Vasilyeva

Dr. Svetlana V. Vasilyeva

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Tetrahedron Letters
Verified
Journal Article
Closed access
TATatyana Abramova
Tatyana Abramova
PBPavel A. Bakharev
Pavel A. Bakharev
SVSvetlana V. Vasilyeva
Svetlana V. Vasilyeva
VSVladimir N. Silnikov
Vladimir N. Silnikov

3 October 2011 in Nucleosides, Nucleotides & Nucleic Acids
Verified
Journal Article
Closed access
SVSvetlana V. Vasilyeva
Svetlana V. Vasilyeva
BBBoris I. Budilkin
Boris I. Budilkin
DKDmitrii A. Konevetz
Dmitrii A. Konevetz
VSVladimir N. Silnikov
Vladimir N. Silnikov
A series of novel nucleoside 5′-triphosphates and phosphoramidites containing alkyne or amino groups for the postsynthetic functionalization of nucleic acids were designed and synthesized. For this purpose, the new 3-aminopropoxypropynyl linker group was used. It contains two alternative functional capabilities: an amino group for the reaction of amino–alkynyl-modified oligonucleotides with corresponding activated esters and an alkyne group for the copper(I)-catalyzed azide–alkyne cycloaddition (CuAAC) reaction. It was shown that a variety of methods of the attachment of the new linker can be used to synthesize a diversity of modified pyrimidine nucleosides.

1 March 2017 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
SVSvetlana V. Vasilyeva
Svetlana V. Vasilyeva
ASAlexander Shtil
Alexander Shtil
APAlbina Sergeevna Petrova
Albina Sergeevna Petrova
SBSergei M. Balakhnin
Sergei M. Balakhnin
PAPolina Y. Achigecheva
Polina Y. Achigecheva
VSVladimir N. Silnikov
Vladimir N. Silnikov

1 February 2013 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
SVSvetlana V. Vasilyeva
Svetlana V. Vasilyeva
VSVladimir N. Silnikov
Vladimir N. Silnikov
NSNatalia V. Shatskaya
Natalia V. Shatskaya
ALAsya S. Levina
Asya S. Levina
MRMarina N. Repkova
Marina N. Repkova
VZValentina F. Zarytova
Valentina F. Zarytova

1 May 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
SVSvetlana V. Vasilyeva
Svetlana V. Vasilyeva
ALAsya S. Levina
Asya S. Levina
NLNikolai Li-Zhulanov
Nikolai Li-Zhulanov
NSNatalia V. Shatskaya
Natalia V. Shatskaya
SBSergei I. Baiborodin
Sergei I. Baiborodin
VSVladimir N. Silnikov
Vladimir N. Silnikov

21 December 2022 in ACS Omega
Verified
Journal Article
Open access
SVSvetlana V. Vasilyeva
Svetlana V. Vasilyeva
EBElizaveta E. Baranovskaya
Elizaveta E. Baranovskaya
EDEvgeniya S. Dyudeeva
Evgeniya S. Dyudeeva
ALAlexander Lomzov
Alexander Lomzov
DPDmitrii Pyshnyi
Dmitrii Pyshnyi
In this work, we present new oligonucleotide derivatives containing inter-nucleotide N-benzimidazole, N-benzoxazole, N-benzothiazole, and 1,3-dimethyl-N-benzimidazole (benzoazoles) phosphoramide groups. These modifications were introduced via the Staudinger reaction with appropriate azides during standard automated solid-phase oligonucleotide synthesis. The principal structural difference between the new azido modifiers and those already known is that they are bulk heterocyclic structures, similar to purine nucleoside bases. Modified oligonucleotides with one and two modifications at different positions and multiple modified heteronucleotide sequences were obtained with high yields. The possibility of multiple modifications in the process of automatic DNA synthesis is fundamental and critical for further application of our oligonucleotide derivatives. Initial studies on the properties of new oligonucleotides were carried out. The stability of the oligodeoxyribonucleotide duplex containing phosphoramide groups of N-benzoazoles with complementary DNA or RNA is slightly lower than that of native complexes.